Insight Molecular Diagnostics Inc. Finance Lease, Liability, to be Paid, Year One
Insight Molecular Diagnostics Inc. (IMDX) had Finance Lease, Liability, to be Paid, Year One of $404.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-10
- 2026-06-30: Finance Lease, Liability, to be Paid, Year One $404.00K.
- 2026-03-31: Finance Lease, Liability, to be Paid, Year One $404.00K.
- 2025-12-31: Finance Lease, Liability, to be Paid, Year One $607.00K.
- 2025-09-30: Finance Lease, Liability, to be Paid, Year One $548.00K.
| Period end | Finance Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $404.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $404.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $607.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $548.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $507.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $433.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $455.00K 10-K · filed 2025-03-24 |
| 2024-09-30 | $455.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $199.00K 10-Q · filed 2024-08-08 |
| 2022-12-31 | $124.00K 10-K · filed 2023-04-12 |
| 2022-09-30 | $124.00K 10-Q · filed 2022-11-10 |
| 2019-09-30 | $67.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $170.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |